Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

MedWellAI (MWAI) EBT (2016 - 2025)

MedWellAI (MWAI) has disclosed EBT for 11 consecutive years, with -$287617.0 as the latest value for Q4 2025.

  • On a quarterly basis, EBT rose 60.58% to -$287617.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$2.8 million, a 145.58% decrease, with the full-year FY2025 number at -$2.9 million, up 67.78% from a year prior.
  • EBT was -$287617.0 for Q4 2025 at MedWellAI, up from -$580888.0 in the prior quarter.
  • In the past five years, EBT ranged from a high of $1.3 million in Q3 2021 to a low of -$22.1 million in Q2 2023.
  • A 5-year average of -$3.1 million and a median of -$694295.5 in 2024 define the central range for EBT.
  • Biggest YoY gain for EBT was 446.59% in 2021; the steepest drop was 3630.14% in 2021.
  • MedWellAI's EBT stood at -$515261.0 in 2021, then plummeted by 48.2% to -$763597.0 in 2022, then skyrocketed by 52.91% to -$359563.0 in 2023, then crashed by 102.93% to -$729660.0 in 2024, then surged by 60.58% to -$287617.0 in 2025.
  • Per Business Quant, the three most recent readings for MWAI's EBT are -$287617.0 (Q4 2025), -$580888.0 (Q3 2025), and -$341537.0 (Q2 2025).